Data-driven subgroups of type 2 diabetes, metabolic response, and renal risk profile after bariatric surgery: a retrospective cohort study
出版年份 2022 全文链接
标题
Data-driven subgroups of type 2 diabetes, metabolic response, and renal risk profile after bariatric surgery: a retrospective cohort study
作者
关键词
-
出版物
Lancet Diabetes & Endocrinology
Volume 10, Issue 3, Pages 167-176
出版商
Elsevier BV
发表日期
2022-02-09
DOI
10.1016/s2213-8587(22)00005-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial
- (2021) Geltrude Mingrone et al. LANCET
- Metabolic surgery versus conventional therapy in type 2 diabetes
- (2021) Alexander D Miras et al. LANCET
- Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
- (2021) Robert Wagner et al. NATURE MEDICINE
- Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes
- (2021) Matthew C. Riddle et al. DIABETES CARE
- Effect of Gastric Bypass vs Best Medical Treatment on Early-Stage Chronic Kidney Disease in Patients With Type 2 Diabetes and Obesity
- (2020) Ricardo Vitor Cohen et al. JAMA Surgery
- Effects of Diet versus Gastric Bypass on Metabolic Function in Diabetes
- (2020) Mihoko Yoshino et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift
- (2019) Christopher J Nolan et al. Diabetes & Vascular Disease Research
- Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data
- (2019) John M Dennis et al. Lancet Diabetes & Endocrinology
- Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study
- (2019) Oana P Zaharia et al. Lancet Diabetes & Endocrinology
- Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
- (2018) Emma Ahlqvist et al. Lancet Diabetes & Endocrinology
- Novel subgroups of patients with adult-onset diabetes in Chinese and US populations
- (2018) Xiantong Zou et al. Lancet Diabetes & Endocrinology
- Insulin action and resistance in obesity and type 2 diabetes
- (2017) Michael P Czech NATURE MEDICINE
- Incidence and Predictive Factors of Postprandial Hyperinsulinemic Hypoglycemia After Roux-en-Y Gastric Bypass
- (2016) Violeta Raverdy et al. ANNALS OF SURGERY
- Mechanisms of Action of Liraglutide in Patients With Type 2 Diabetes Treated With High-Dose Insulin
- (2016) Anna Vanderheiden et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms
- (2016) Luigi Gnudi et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study
- (2013) Christopher D Still et al. Lancet Diabetes & Endocrinology
- Diabetes: Have We Got It All Wrong?: Hyperinsulinism as the culprit: surgery provides the evidence
- (2012) W. J. Pories et al. DIABETES CARE
- Clinical Usefulness of a New Equation for Estimating Body Fat
- (2011) J. Gomez-Ambrosi et al. DIABETES CARE
- Roux-en-Y Gastric Bypass Corrects Hyperinsulinemia Implications for the Remission of Type 2 Diabetes
- (2011) Melissa A. Reed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Reduced Time Points to Calculate the Composite Index
- (2010) R. A. DeFronzo et al. DIABETES CARE
- Beta cell (dys)function in non-diabetic offspring of diabetic patients
- (2009) M. Stadler et al. DIABETOLOGIA
- General Cardiovascular Risk Profile for Use in Primary Care
- (2008) Ralph B. D’Agostino et al. CIRCULATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started